Upper Gastrointestinal Biopsy

Publication Date: October 1, 2015

Key Points

Key Points

  • The purpose of the current guideline is to establish evidence-based practicing standards for the performance of biopsies of normal-appearing mucosa in the upper gastrointestinal tract.
  • Dyspepsia is defined according to the Rome III criteria, which include ≥1 of the following symptoms: bothersome postprandial fullness, early satiation, epigastric pain, and epigastric burning.
  • The guideline assumes no prior treatment for Helicobacter pylori (HP) infection.

Diagnosis

Diagnos...

...e III Criteria for Functional Dyspepsia...


...testinal Biopsy to Evaluate Dyspeps...


...y of Recommendations from the AGA Guidel...

...phagusIn patients undergoing EGD for dyspepsia...

...hIn immunocompetent patients undergoing EGD fo...

...immunocompromised patients undergoing EGD fo...

...obtaining biopsies from the normal-appea...

...opsies are obtained from the normal-appearing gast...

...um In patients undergoing EGD for dyspep...

...ised patients undergoing EGD for d...

...hen biopsies are obtained from the nor...


...Gastric Biopsy Recommended by the Up...